Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Australasian Leukaemia and Lymphoma Group (ALLG)
Scientific Title
A phase Ib/II clinical evaluation of Ponatinib in combination with 5-azacytidine in patients failing prior therapy for FLT3-ITD positive acute myeloid leukaemia (AML M21)